We are live on ! Find out more
INBS icon

Intelligent Bio Solutions
INBS

4 hedge funds and large institutions have $651K invested in Intelligent Bio Solutions in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

766% more capital invested

Capital invested by funds: $75.1K → $651K (+$576K)

0.13% more ownership

Funds ownership: 0% → 0.13% (+0.13%)

50% less funds holding

Funds holding: 8 → 4 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
4
Holders Change
-4
Holders Change %
-50%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$968K
2
Walleye Capital
Walleye Capital
New York
+$735K
3
TRCT
Tower Research Capital (TRC)
New York
+$22K
4
UBS Group
UBS Group
Switzerland
+$918

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$23K
2
Renaissance Technologies
Renaissance Technologies
New York
-$21K
3
Citadel Advisors
Citadel Advisors
Florida
-$13.9K
4
State Street
State Street
Massachusetts
-$6.82K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$3.38K

INBS Hedge Fund Activity: Q1 2023 in Review

4 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q1 2023, worth a combined $651K — up 766% from $75.1K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of INBS and 3 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $968K. The largest seller was Geode Capital Management, exiting entirely with an estimated $23K sold.

  • 4 institutional investors held Intelligent Bio Solutions (INBS) as of Q1 2023, down from 8 in Q4 2022.
  • Funds reported $651K of Intelligent Bio Solutions stock for Q1 2023, up 766% quarter-over-quarter.
  • 3 funds opened new Intelligent Bio Solutions positions in Q1 2023 and 7 closed out, a net change of -4 holders.
  • The largest Intelligent Bio Solutions buyer in Q1 2023 was Sabby Management, an estimated $968K added.
  • The largest Intelligent Bio Solutions seller in Q1 2023 was Geode Capital Management, an estimated $23K sold.

Based on aggregated 13F filings for Q1 2023.